Is RIV Capital Inc. (CNPOF) a Buy, Sell, or Hold?
RIV Capital Inc.
PNK:CNPOF
$0.095 USD
$0.0 (0.53%)
- Volume
- 1K
- Average Volume
- 87.52K
- Market Capitalization
- $12.97M
- P/E Ratio
- -0.16
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.17
- Year Low
- $0.06
- Payout Ratio
- $0.00
- Current Ratio
- $6.99
Industry, Sector & symbol
| Stock Exchange | Other OTC |
| CEO | Mr. David E. Vautrin |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | CNPOF |
| CUSIP | None |
| CIK | None |
| Web | https://www.rivcapital.com |
| Phone | 416-583-5945 |
| Currency | USD |
| Employees | 94 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 3.34 |
| Payout Ratio | 0.00 |
| Current Ratio | 6.99 |
| Quick Ratio | 5.86 |
| Cash Ratio | 5.50 |
Sales & Book Value
| Annual Sales | $5.64M |
| Price / Sales | 1.45 |
| Cash Flow | -0.20 |
| Price / Cash Flow | -0.41 |
| Price / Book | 0.30 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $126726356 |
| Trailing P/E Ratio | -0.16 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | $-80.38M |
| Net Margin | -905.10% |
| Pretax Margin | -1141.84% |
| Return on Equity | -91.77% |
| Return on Assets | -34.13% |
Financials Score
| AltmanZ Score | -2.47 |
| Piotroski Score | 4.00 |
| Working Capital | 71.77M |
| Total Assets | 205.22M |
| Ebit | -20.07M |
| Market Cap | 12.97M |
| Total Liabilities | 167.7M |
Poll Results
About RIV Capital Inc. (PNK:CNPOF) Stock
RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, and media and content. The firm also focuses on beverages, capsules and concentrates, edibles, dry flower / pre-rolls, vaporizers and hardware, pet products, and topicals. In agriculture and food sciences firm focuses in invest plant science, soil science, food science, animal science and environmental ... science. In production firm focuses in Indoor cultivation, greenhouse cultivation, outdoor cultivation, nursery cultivation and fermentation. In processing firm focuses in harvesting, extraction and purification, packaging, food and beverage processing and laboratory testing services. In pharmaceuticals and biotechnology firm focuses in pharmaceutical discovery and development, delivery method (ex: pill, soft gel, tincture), biosynthetic derived cannabinoids and other molecules, medical devices (ex: inhalers) and lab equipment. In consumer products and accessories firm focuses in edibles, beverages, inhalable, cosmetics and cannabis consumption accessories. In retail and distribution firm focuses in licensed brick and mortar retailers, pharmacies, online consumer marketplaces, delivery services, and others. The firm invests in opportunities globally. The firm prefers to invest in check sizes have ranged from CA$1 million ($0.71 million) to $40 million ($28.45 million), but more typical investment range is between CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm is focused on making minority stake investments. Firm employ diverse investment structures including debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was founded on 2017 and is based in Toronto, Canada.
RIV Capital Reports Financial Results for the Third Quarter Ended September 30, 2024
2024-11-29 08:00:00
Company reports record quarterly revenue of $4.9 million Adjusted EBITDA1 loss improves; net loss primarily driven by non-cash pre-tax impairment charge on intangible assets Ended the quarter with $50.7 million of cash to support growth initiatives in New York and Florida Cansortium Business Combination anticipated to close in the coming weeks TORONTO , Nov. 29, 2024 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), a firm dedicated to developing a leading multi-state platform with a strong portfolio of cannabis brands focused on key strategic markets in the United States ("U.S."), today released its financial results for the third quarter ended September 30, 2024 ("Q3 2024"). All financial information in this press release is reported in U.S. dollars unless otherwise indicated.
2024-10-24 08:30:00
Significant Year-Over-Year Net Revenue Growth Driven by Robust Retail Performance Following Adult-Use Sales Launch in New York and Strong Bulk Wholesale Performance Pace of Synergy Realization faster than Expected, Strongly Positioning the Company for its Anticipated Business Combination with Cansortium TORONTO , Oct. 24, 2024 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform, today announced an operational update highlighting the Company's recent achievements ahead of its previously announced business combination with Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium"), a vertically integrated, multi-state cannabis company operating under the FLUENT™ brand (the "Business Combination"). Recent Operational Highlights: Based on preliminary estimates of financial results, year-to-date net revenue, as of October 23, 2024, doubled compared to the same period in the prior calendar year, with substantial growth in the third quarter of 2024 ("Q3 2024") and momentum expected to continue to build in the fourth quarter of 2024.
RIV Capital Establishes Distribution Partnership with Nabis
2024-10-16 17:00:00
Strategic Partnership Poised to Boost Market Penetration and Streamline Operations, Accelerating RIV Capital's Growth in New York's Thriving Market TORONTO , Oct. 16, 2024 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform, today announced a distribution partnership agreement with Siban Holdings, Inc. ("Nabis") (the "Agreement"), a leading wholesale platform in the cannabis industry. Under the terms of the Agreement, Nabis's technology and expertise will facilitate distribution for the Company's branded products to licensed retailers across New York state.
2024-10-10 14:25:00
Transaction expected to close in the fourth quarter of 2024 TORONTO , Oct. 10, 2024 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform, and Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium"), a vertically integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced that they have received New York Cannabis Control Board approval for their previously announced business combination (the "Business Combination"). "We are thrilled to have received regulatory approval in New York to move forward with our business combination transaction, bringing us closer to completing this important step for both of our companies in the fourth quarter of 2024," said Robert Beasley, Chief Executive Officer of Cansortium.
RIV Capital and Etain Commence Adult-Use Sales at Kingston Dispensary
2024-10-08 07:30:00
TORONTO , Oct. 8, 2024 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform, is pleased to announce that Etain has commenced co-located adult-use sales at its existing medical dispensary located at 445 NY-28, Kingston, New York. The opening follows the Company's recent launch of adult-use sales at its Etain Manhattan location, as well as the New York debut of the MOODS line of branded cannabis products.
Frequently Asked Questions
-
What is the current RIV Capital Inc. (CNPOF) stock price?
-
RIV Capital Inc.(PNK:CNPOF) stock price is $0.095 in the last trading session. During the trading session, CNPOF stock reached the peak price of $0.169 while $0.062 was the lowest point it dropped to. The percentage change in CNPOF stock occurred in the recent session was 0.53% while the dollar amount for the price change in CNPOF stock was $0.0.
-
CNPOF's industry and sector of operation?
-
The PNK listed CNPOF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of CNPOF?
-
Mr. Sean McNulty | Co-Founder & Advisor
Mr. Edward James Cirillo Lucarelli | Chief Financial Officer
Mr. Matthew Jonathon Mundy | Chief Strategy Officer, General Counsel & Corporate Secretary
Mr. David E. Vautrin | Chief Retail Officer & Interim Chief Executive Officer
Mr. Peter Hatziioannou | Co-Founder & Advisor -
How many employees does CNPOF have?
-
Number of CNPOF employees currently stands at 94. CNPOF operates from 40 King Street West, Toronto, ON M5H 3Y2, CA.
-
Link for CNPOF official website?
-
Official Website of CNPOF is: https://www.rivcapital.com
-
How do I contact CNPOF?
-
CNPOF could be contacted at phone #416-583-5945 and can also be accessed through its website. CNPOF operates from 40 King Street West, Toronto, ON M5H 3Y2, CA.
-
How many shares of CNPOF are traded daily?
-
The average number of CNPOF shares traded daily for last 3 months was 87.52K.
-
What is the market cap of CNPOF currently?
-
The market value of CNPOF currently stands at $12.97M with its latest stock price at $0.095